BackgroundCheck.run
Search For

David L Earnest, 851526 E Adelaide Dr, Tucson, AZ 85719

David Earnest Phones & Addresses

1526 E Adelaide Dr, Tucson, AZ 85719   

Morristown, NJ   

White Plains, NY   

5225 N Calle Ladero, Tucson, AZ 85718   

Work

Position: Executive, Administrative, and Managerial Occupations

Education

School / High School: Pace Law School

Ranks

Licence: New York - Currently registered Date: 2006

Mentions for David L Earnest

Career records & work history

Lawyers & Attorneys

David Earnest Photo 1

David Lewis Earnest - Lawyer

Address:
Hogan Lovells International LLP
Licenses:
New York - Currently registered 2006
Education:
Pace Law School

David Earnest resumes & CV records

Resumes

David Earnest Photo 44

Independent Developer

Industry:
Information Technology And Services
Work:
David Earnest
Independent Developer
David Earnest Photo 45

David Earnest

David Earnest Photo 46

David Earnest

David Earnest Photo 47

David Earnest

David Earnest Photo 48

David Earnest

Location:
United States
David Earnest Photo 49

David Earnest

Location:
United States
David Earnest Photo 50

David Earnest

Location:
United States

Publications & IP owners

Us Patents

Compositions And Methods For Treating Diseases

US Patent:
2009016, Jun 25, 2009
Filed:
Jun 13, 2007
Appl. No.:
12/308163
Inventors:
David Lewis Earnest - Morristown NJ, US
Assignee:
Novartis AG - Basel
International Classification:
A61K 31/4439
A61K 31/404
US Classification:
514338, 514415
Abstract:
This invention relates to methods for treating, preventing and/or managing gastric injury, e.g., NSAID-induced gastric injury in a subject including administering to the subject tegaserod, alone or in combination with a proton pump inhibitor. Also provided are compositions and kits for use in methods of the invention.

Applicator For Hair Building Solids

US Patent:
2009019, Aug 13, 2009
Filed:
Apr 8, 2004
Appl. No.:
11/666345
Inventors:
Mark Kress - Westport CT, US
David Earnest - Los Angeles CA, US
International Classification:
A41G 5/00
B05B 11/06
US Classification:
132201, 222633
Abstract:
An improved applicator for hair building cosmetic fibers, powders and particles uses a gentle stream of gas to suspend the fibers and waft them onto the user's scalp. A low pressure, low velocity gas stream directed downwards into a mass of fibers in a closed container suspends them. The suspended fibers exit through a small orifice connected with a passageway ending in a nozzle. The suspended fibers are propelled from the bulb in a directed fashion to settle naturally in a controlled area. If a rubber bulb is used to supply air to suspend the fibers, a user can gently squeeze the bulb to allow controlled puffs of air and fibers to waft onto controlled regions of the scalp. A valve arrangement can be operated to provide an air stream to remove excess deposited fibers from regions of the scalp.

Organic Compounds

US Patent:
2009022, Sep 3, 2009
Filed:
Dec 20, 2006
Appl. No.:
12/086656
Inventors:
David Lewis Earnest - Morristown NJ, US
International Classification:
A61K 31/405
A61K 31/22
US Classification:
514415, 514551
Abstract:
The present invention relates to a combination of a 5-HT4 receptor agonist and a cholinesterase inhibitor and pharmaceutical compositions and formulations containing the combination. The pharmaceutical combination may be employed for the treatment of altered gastrointestinal motility, sensitivity, secretion or abdominal disorders. The dosage is preferably oral. The preferred 5-HTreceptor agonist is tegaserod.

Method For The Prevention Of Colonic Adenomas

US Patent:
6677328, Jan 13, 2004
Filed:
Oct 18, 2000
Appl. No.:
09/691496
Inventors:
Carroll Wayne Allen - Chatham NJ
Thomas Albert Brasitus - Olympia Fields IL
David Lewis Earnest - Tuscon AZ
Gerald Leigh Messerschmidt - Mendham NJ
Assignee:
Novartis Corp. - New York City NY
University of Chicago - Chicago IL
University of Arizona - Tucson AZ
International Classification:
A61K 3156
US Classification:
514182, 514169, 424489, 424490, 424451, 424472
Abstract:
Method for the prevention of colonic adenomas in mammals at risk of developing them by administering to such mammals an effective colonic adenoma preventive amount of ursodiol or a pharmaceutically acceptable salt conjugation product thereof.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.